Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genetic Signatures is a specialist molecular diagnostics company that designs and manufactures real-time PCR based products for the routine detection of infectious diseases. The company's proprietary 3base™ technology simplifies the genomic sequence of pathogens by converting a four-base sequence into a three-base sequence, significantly reducing sequence complexity and improving detection accuracy across multiple strains. Their flagship EasyScreen™ Detection Kits provide high-throughput, multiplexed solutions for clinical laboratories targeting enteric, respiratory, and sexually transmitted pathogens. Headquartered in Sydney, Australia, the company is focused on expanding its global commercial footprint in Europe and North America. The technology is particularly effective for detecting highly variable viruses and bacteria where traditional PCR might fail due to mutations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Human Genetic Signatures.